Evidence map›Paper›PMID 41717129›Full record

ArticleKidney international reports2026

Impact of CKD on Life Participation in Latin America.

Andrea Matus Gonzalez, Anastasia Hughes, Soledad Molina, Macarena Arancibia, Alejandro Sepulveda, Ana Malvar, Alejandro Ferreiro, Haydee Mellado, Eduardo Lorca, Hernan Trimarchi and 18 more

Abstract read
In one paragraph

Article in Kidney international reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors.

Andrea Matus GonzalezSydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Anastasia HughesSydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Soledad MolinaSantiago, Chile.
Macarena ArancibiaCardiorenal Nutrition Centre, Santiago, Chile.
Alejandro SepulvedaCardiorenal Nutrition Centre, Santiago, Chile.
Ana MalvarHospital Fernández, Nephrology Unit, Buenos Aires, Argentina.
Alejandro FerreiroFacultad de Medicina, Universidad de la República., Programa de Salud Renal de Uruguay., Montevideo, Uruguay.
Haydee MelladoClínica Dávila, Santiago, Chile.
Eduardo LorcaEastern Department of Internal Medicine, Faculty of Medicine, University of Chile, Santiago, Chile.
Hernan TrimarchiNephrology Service and Kidney Transplant Unit, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Rolando Claure-Del GranadoDivision of Nephrology, Department of Medicine, Hospital Obrero No 2 - Caja Nacional de Salud, Universidad Mayor de San Simon School of Medicine, Cochabamba, Bolivia.
Chandana GuhaSydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Lilia CervantesDivision of Hospital Medicine, Department of Medicine, University of Colorado, Anschutz Medical Campus, Aurora, Colorado, USA.
Adeera LevinDivision of Nephrology, University of British Columbia, Vancouver, British Colombia, Canada.
Claudio A MascheroniServicio de Nefrología San Pedro. Bs As. Universidad Nacional de Rosario, Rosario, Santa Fe, Argentina.
Linda WengServicio de Nefrología San Pedro. Bs As. Universidad Nacional de Rosario, Rosario, Santa Fe, Argentina.
Germaine WongSydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Laura SolaLatin American Society of Nephrology and Hypertension-SLANH, Panama City, Panama.
Mauro LampoNephrology Service and Kidney Transplant Unit, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Matias MonkowskiNephrology Service and Kidney Transplant Unit, Hospital Británico de Buenos Aires, Buenos Aires, Argentina.
Andrea K ViecelliAustralasian Kidney Trials Network, Faculty of Medicine, University of Queensland, Brisbane, Queensland, Australia.
Brooke HuuskesDepartment of Microbiology, Anatomy, Physiology and Pharmacology, School of Agriculture, Biomedicine and Environment, La Trobe University, Bundoora, Victoria, Australia.
Karine ManeraSydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Javier Recabarren SilvaSydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Armando Teixeira-PintoSydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Jonathan C CraigCollege of Medicine and Public Health, Flinders University, Adelaide, South Australia, Australia.
Allison JaureSydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia.
Life Participation Workshop Investigators

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Patients with chronic kidney disease (CKD) carry symptom and treatment burden, which together with comorbidities, can impair their ability to engage in life activities. Different values and priorities regarding life participation may vary depending on the population and setting. We aimed to describe the perspectives of life participation in patients with CKD not requiring kidney replacement therapy (KRT) in Latin America. Methods: In April 2024, we conducted a workshop with facilitated breakout groups (small group discussions) involving patients, caregivers, and health care professionals in Spanish language to discuss the impact of CKD on life participation in patients with CKD. Transcripts were analyzed thematically. Results: Sixty-six participants, including 51 patients and caregivers, and 15 health care professionals from 5 countries (Argentina, Chile, Uruguay, Bolivia, and Peru) attended. Five themes were identified as follows: despair and sense of doom (coming to a sudden halt, diminished involvement in social activities with family and friends, paralyzing fear, fragility and vulnerability, and losing mental fortitude); stigmatized and judged (alone in the diagnosis, reprimanded for dietary choices, and discriminated by employers and colleagues); debilitating symptoms (incapacitated by pain and fatigue impairing functioning); threatening life goals (obscuring decision-making around family planning and relinquishing career aspirations); and garnering hope and strengthening resilience (overcoming challenges with family support, finding strength in spirituality, encouraged by clinicians, and physical activity to promote well-being). Conclusion: Patients with CKD experienced despair, hopelessness, loneliness and isolation, debilitating symptoms, and uncertainty about their family and vocational goals, which contributed to impaired life participation. Strategies are needed to address these challenges to enhance the capacity of patients to live well with CKD.

Indexed as

chronic kidney diseaselife participationpatient-centered outcomesquality of life

Identifiers

PMID41717129
PMCPMC12915224

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.